Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Journal of Nephrology & Renal DiseasesISSN: 2576-3962
https://sporbahisleri.livejournal.com https://wakelet.com/@SporBahisleri67459 https://theomnibuzz.com/author/sporbahisleri/ https://lessons.drawspace.com/profile/322207/sporbahisleri/workflow https://writeupcafe.com/profile/sporbahisleri/ http://www.pearltrees.com/sporbahisleri https://pharmahub.org/members/26874/blog https://www.zupyak.com/u/Spor-Bahisleri/ https://www.metroflog.co/sporbahisleri https://www.fuzia.com/fz/spor-bahisleri https://tr.pinterest.com/sporbahislerim/ https://my.getjealous.com/sporbahisleri https://sporbahisleri.contently.com https://hubpages.com/@sporbahisleri https://www.tumblr.com/sporbahisleri https://hub.docker.com/u/sporbahislerim https://betsiteleri.blogfree.net https://betsiteleri.amebaownd.com https://sporbahisleri.pixnet.net/blog https://betsiteleri.seesaa.net https://betsiteleri.threadless.com https://betsiteleri.neocities.org https://bahissiteleri.localinfo.jp https://betsiteleri.shopinfo.jp https://teletype.in/@betsiteleri https://ubl.xml.org/users/sporbahisleri https://betsiteleri.educatorpages.com https://betsiteleri.onlc.fr https://sporbahisleri.gumroad.com
G. Anvesh Author
Subjects of specialization
Affiliation
Nephrology
Nizam
Biography
Dr. G. Anvesh is a Nephrologist with a special interest in Renal transplantation. He is the best outgoing student in DM Nephrology from the Nizam’s Institute of Medical Sciences, India and has many Publications in peer reviewed journals to his credit. He is presently a Reviewer for Indian Journal of Nephroloy. He had also presented in many National and International Conferences and have been constantly expanding and sharing his knowledge with his colleagues all over the world. He has a vivid experience in treating and managing the complications after the renal transplants.
Publications
Annual Meeting Abstract Open Access
Marginal donors in renal transplantation
Author(s): G. Anvesh
The ageing global population and the increased life expectancy have contributed to the rise in the prevalence of older patients with end stage renal failure (ESRD). Renal transplantation is the best treatment option for eligible patients with end stage renal disease. The number of renal transplants has increased rapidly over the last two decades across the world which increased the demand for donor organs. This disparity between the availability of organs and waitlisted patients for transplants has forced many transplant centres across the world to use marginal kidneys and donors. Deceased donor organ transplant (DDOT) with “marginal donors” or extended criteria donor (ECD) is increasing in number. In the United States, 15-20% of donors were ECD in 2008. About 30% and 47% of... view more»
Google Scholars / Researchers Sites
